Mar 18 |
Exagen reports Q4 results
|
Mar 18 |
Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates
|
Mar 18 |
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
|
Mar 18 |
Earnings Scheduled For March 18, 2024
|
Mar 8 |
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
|
Mar 7 |
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
|
Feb 6 |
Despite Fast-paced Momentum, Exagen Inc. (XGN) Is Still a Bargain Stock
|
Jan 8 |
Exagen reaffirms FY23 revenue of at least $50M
|
Jan 7 |
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
|